Effects of levosimendan in patients with severe functional mitral regurgitation undergoing MitraClip implantation

Conclusion: Prophylactic levosimendan did not affect long-term outcome in patients undergoing PMVR. However, levosimendan as an adjunctive therapy to MitraClip implantation offers further therapeutic advantages in patients with advanced heart failure by improving systolic right ventricle function.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Mitral valve disease Source Type: research